Date/Time | Room 1 | Room 2 | Room 3 | Room 4 |
---|---|---|---|---|
Vista 1 (B2F) | Vista 2 (B2F) | Grand 1 (B1F) | Art Hall (4F) | |
08:50-09:00 | Opening Remark | |||
09:00-10:15 | Joint Session 01 (MOU Session) Adult Acute Lymphoblastic Leukemia in Asia | Scientific Session 01 Improving Outcomes in Challenging Pediatric Leukemia | Scientific Session 02 Overcoming the Resistance Mechanisms of Multiple Myeloma | Education Session 01 Understanding the Fundamentals of Myelodysplastic Syndrome KOR |
10:15-10:30 | Break | |||
10:30-11:15 | Plenary Lecture 01 Myeloproliferative Neoplasms: 2025 update | |||
11:15-12:00 | Presidential Symposium 01 CAR T-cell therapy for Lymphomas: Current and future trends | |||
12:00-12:15 | Break | |||
12:15-13:05 |
Satellite Symposium 01
![]() |
Satellite Symposium 02
![]() |
Satellite Symposium 03
![]() |
Satellite Symposium 04
![]() |
13:05-13:45 | Poster Viewing 1 (Walker Hall, 1F) | |||
13:45-13:55 | Break | |||
13:55-15:10 | Oral Presentation 01Acute Leukemia (AML) | Oral Presentation 02Laboratory Hematology | Oral Presentation 03Lymphoma | Oral Presentation 04Chronic Myeloid Leukemia / Myeloproliferative Neoplasm / Myelodysplastic Syndrome |
15:10-15:25 | Break | |||
15:25-16:40 | Joint Sesseion 02 (EHA-KSH) Acute Myeloid Leukemia - Research and Practice | Scientific Session 03 Updates in Cancer-Associated Venous Thromboembolism | Scientific Session 04 Advancements in Peripheral T-cell Lymphoma:From Biological Insights to Innovative Treatments | Education Session 02 Basic Understanding and Application of Artificial Intelligence KOR |
16:40-16:55 | Break | |||
16:55-18:10 | Scientific Session 05 Red Blood Cells in Myeloproliferative Neoplasm | Scientific Session 06 Advances and Challenges in Histiocytic Diseases: A Comprehensive Update | Scientific Session 07 Breaking New Ground in Acute Myeloid Leukemia | Education Session 03 Turning Ideas into Successful Clinical Trial: A Practical Approach KOR |
18:45~ | Welcome Reception (Aston House) |
Time | Room 1 Vista 1 (B2F) |
Room 2 Vista 2 (B2F) |
Room 3 Grand 1 (B1F) |
Room 4 Art Hall (4F) |
Room 5 Grand 4+5 (B1F) |
---|---|---|---|---|---|
09:00-10:15 | Joint Session 03 (ASH-KSH) Chronic Myeloid Leukemia - Era of Next-Generation Sequencing | Scientific Session 08 TP53 Alterations in Hematological Malignancy: From Clonal Hematopoiesis to Acute Leukemia | Scientific Session 09 Advancing the Paradigm in Adult Acute Lymphoblastic Leukemia Care | Education Session 04 Minimal Residual Disease: Tailored Treatment Strategies for Hematologic Malignancies | |
10:15-10:30 | Break | ||||
10:30-11:15 | Plenary Lecture 02 From ancient origins to modern tools: CD38's evolutionary legacy in science and clinical practice | ||||
11:15-12:00 | Poster Viewing 2 (Walker Hall, 1F) | ||||
12:00-12:15 | Break | ||||
12:15-13:05 |
Satellite Symposium 05
![]() |
Satellite Symposium 06
![]() |
Satellite Symposium 07
![]() |
Satellite Symposium 08
![]() |
Satellite Symposium 09
![]() |
13:05-13:35 | Break | ||||
13:35-14:50 | Oral Presentation 05Acute Leukemia (ALL) | Oral Presentation 06Others | Oral Presentation 07Multiple Myeloma | Oral Presentation 08Hematopoietic Stem Cell Transplantation / Cellular Therapy | |
14:50-15:05 | Break | ||||
15:05-16:20 | Education Session 05 Up-to-Date Management of Multiple Myeloma | Scientific Session 10 Next Steps toward Enhanced Treatment for Pediatric Lymphoid Malignancies | Scientific Session 11 Driving the Future of our CAR |
Education Session 06
Patient Care in Cytopenia Consultations: Best Practices for Hematologists KOR |
|
16:20-16:35 | Break | ||||
16:35-17:50 | Joint Session 04 (Asia Session) Dawn of CAR-T Therapy: Asian Perspective | Scientific Session 12 Cutting-Edge Diagnostic Techniques in Hematology | Scientific Session 13 Innovations in Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria | Education Session 07 Treatment of Indolent & Hodgkin Lymphoma | |
18:30~ | Gala Dinner (Théâtre des Lumières) |
Time | Room 1 Vista 1 (B2F) |
Room 2 Vista 2 (B2F) |
Room 3 Grand 1 (B1F) |
Room 4 Art Hall (4F) |
---|---|---|---|---|
07:30-08:00 | KSH Business Meeting | |||
08:00-08:30 | Young Investigator Award Presentation | |||
08:30-09:00 | ||||
09:00-10:15 | Joint Session 05 (Asia Session) MRD and Immunotherapy in Multiple Myeloma: Collaborative Insights from Korea and Japan | Scientific Session 14 Deciphering Blood Coagulation Tests | Scientific Session 15 Immunotherapy in B-cell Lymphoma: Current Status and Emerging Approaches | Education Session 08 Supportive Care: Management of Infections and Iron Overload KOR |
10:15-10:30 | Break | |||
10:30-11:15 | Plenary Lecture 03 New discoveries that will shape future therapies in Chronic Myeloid Leukemia | |||
11:15-11:30 | Break | |||
11:30-12:00 | Closing Ceremony | |||
12:00-12:30 | KSH General Assembly |